Gerdes AM - Search Results

1

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard J, Soucy P, Eeles RA, Easton DF, Hamann U, Wilkening S, Chen B, Rookus MA, Schmidt MK, van der Baan FH, Spurdle AB, Walker LC, Lose F, Maia AT, Montagna M, Matricardi L, Lubinski J, Jakubowska A, Gómez Garcia EB, Olopade OI, Nussbaum RL, Nathanson KL, Domchek SM, Rebbeck TR, Arun BK, Karlan BY, Orsulic S, Lester J, Chung WK, Miron A, Southey MC, Goldgar DE, Buys SS, Janavicius R, Dorfling CM, van Rensburg EJ, Ding YC, Neuhausen SL, Hansen TV, Gerdes AM, Ejlertsen B, Jønson L, Osorio A, Martínez-Bouzas C, Benitez J, Conway EE, Blazer KR, Weitzel JN, Manoukian S, Peissel B, Zaffaroni D, Scuvera G, Barile M, Ficarazzi F, Mariette F, Fortuzzi S, Viel A, Giannini G, Papi L, Martayan A, Tibiletti MG, Radice P, Vratimos A, Fostira F, Garber JE, Donaldson A, Brewer C, Foo C, Evans DG, Frost D, Eccles D, Brady A, Cook J, Tischkowitz M, Adlard J, Barwell J, Walker L, Izatt L, Side LE, Kennedy MJ, Rogers MT, Porteous ME, Morrison PJ, Platte R, Davidson R, Hodgson SV, Ellis S, Cole T; EMBRACE; Godwin AK, Claes K, Van Maerken T, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D, Steinemann D, Plendl H, Kast K,… See abstract for full author list ➔ Peterlongo P, et al. Among authors: gerdes am. Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):308-16. doi: 10.1158/1055-9965.EPI-14-0532. Epub 2014 Oct 21. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25336561 Free PMC article.

2

Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue.

Dietrich CU, Pandis N, Teixeira MR, Bardi G, Gerdes AM, Andersen JA, Heim S. Dietrich CU, et al. Among authors: gerdes am. Int J Cancer. 1995 Jan 3;60(1):49-53. doi: 10.1002/ijc.2910600107. Int J Cancer. 1995. PMID: 7814151

3

Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors.

Pandis N, Teixeira MR, Gerdes AM, Limon J, Bardi G, Andersen JA, Idvall I, Mandahl N, Mitelman F, Heim S. Pandis N, et al. Among authors: gerdes am. Cancer. 1995 Jul 15;76(2):250-8. doi: 10.1002/1097-0142(19950715)76:2<250::aid-cncr2820760215>3.0.co;2-w. Cancer. 1995. PMID: 8625100

4

Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.

Håkansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes AM, Holmberg E, Dahl N, Pandis N, Kristoffersson U, Olsson H, Borg A. Håkansson S, et al. Among authors: gerdes am. Am J Hum Genet. 1997 May;60(5):1068-78. Am J Hum Genet. 1997. PMID: 9150154 Free PMC article.

5

Fluorescence in situ hybridization of old G-banded and mounted chromosome preparations.

Gerdes AM, Pandis N, Bomme L, Dietrich CU, Teixeira MR, Bardi G, Heim S. Gerdes AM, et al. Cancer Genet Cytogenet. 1997 Oct 1;98(1):9-15. doi: 10.1016/s0165-4608(96)00407-4. Cancer Genet Cytogenet. 1997. PMID: 9309112

6

Prognosis and clinical presentation of BRCA2-associated breast cancer.

Loman N, Johannsson O, Bendahl P, Dahl N, Einbeigi Z, Gerdes A, Borg A, Olsson H. Loman N, et al. Eur J Cancer. 2000 Jul;36(11):1365-73. doi: 10.1016/s0959-8049(00)00098-8. Eur J Cancer. 2000. PMID: 10899649

7

Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

Vallon-Christersson J, Cayanan C, Haraldsson K, Loman N, Bergthorsson JT, Brøndum-Nielsen K, Gerdes AM, Møller P, Kristoffersson U, Olsson H, Borg A, Monteiro AN. Vallon-Christersson J, et al. Among authors: gerdes am. Hum Mol Genet. 2001 Feb 15;10(4):353-60. doi: 10.1093/hmg/10.4.353. Hum Mol Genet. 2001. PMID: 11157798 Free PMC article.

8

Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation.

Thomassen M, Kruse TA, Olsen KE, Borg A, Gerdes AM. Thomassen M, et al. Among authors: gerdes am. Breast Cancer Res Treat. 2004 Oct;87(3):273-6. doi: 10.1007/s10549-004-9503-3. Breast Cancer Res Treat. 2004. PMID: 15528970

9

'Indirect' BRCA1/2 testing: a useful approach in hereditary breast and ovarian cancer families without a living affected relative.

Cruger DG, Kruse TA, Gerdes AM. Cruger DG, et al. Among authors: gerdes am. Clin Genet. 2005 Sep;68(3):228-33. doi: 10.1111/j.1399-0004.2005.00484.x. Clin Genet. 2005. PMID: 16098011

10

A missense mutation in exon 13 in BRCA2, c.7235G>A, results in skipping of exon 13.

Thomassen M, Kruse TA, Jensen PK, Gerdes AM. Thomassen M, et al. Among authors: gerdes am. Genet Test. 2006 Summer;10(2):116-20. doi: 10.1089/gte.2006.10.116. Genet Test. 2006. PMID: 16792514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters